Visit KQAK 105.7
Visit The Peak 104.1
Visit 95.7 The Ranch
Visit 92.5 The Ticket
Visit KBNW 104.5AM AND 1340AM
Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Medera Inc.

News headline image
Medera's Novoheart Technology Powers Advanced Human Cardiac Disease Modeling at Singapore's New CIPHER Research Centre
From Medera Inc.
Via GlobeNewswire
News headline image
Medera Expands Singapore Presence Through Partnership with National Heart Centre Singapore
From Medera Inc.
Via GlobeNewswire
News headline image
Medera Presents Late-Breaking Clinical Trial Data at ESC Congress 2026 Demonstrating Durable Improvement in HFpEF Cardiac Filling Pressures Following SRD-002 Gene Therapy
From Medera Inc.
Via GlobeNewswire
News headline image
IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery
From Medera Inc.
Via GlobeNewswire
Tickers IQV
News headline image
Medera Announces Independent Data Monitoring Committee (DMC) Recommends Continued Advancement of Lead HFpEF Gene Therapy Program
From Medera Inc.
Via GlobeNewswire
News headline image
Medera Expands Scientific Advisory Board with Leading Heart Failure and Cardiopulmonary Physiology Experts to Advance HFpEF Gene Therapy Program
From Medera Inc.
Via GlobeNewswire
News headline image
Medera Receives FDA Fast Track Designation for Gene Therapy Targeting Duchenne Muscular Dystrophy-Associated Cardiomyopathy
From Medera Inc.
Via GlobeNewswire
News headline image
Medera Announces Completion of Patient Enrollment in Cohort B of MUSIC-HFpEF Phase 1/2a Clinical Trial
From Medera Inc.
Via GlobeNewswire
News headline image
Medera to Participate in Oppenheimer Movers in Rare Disease Summit 2025
From Medera Inc.
Via GlobeNewswire
News headline image
Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at American Heart Association Scientific Sessions 2025
From Medera Inc.
Via GlobeNewswire
News headline image
Medera Announces First Patient Dosed in Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial Evaluating SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction
From Medera Inc.
Via GlobeNewswire
News headline image
Medera Strengthens Leadership Team with Three Key Executive Appointments
From Medera Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.